Notice Information
Notice Title
Hepatitis C Medicines
Notice Description
This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing was requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap
Lot Information
Treatment Spend Cap
This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).
Treatment Cost per MedicineThis Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000574398
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN356232
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £45,000,000 £10M-£100M
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £32,583,333 £10M-£100M
Notice Dates
- Publication Date
- 4 Jun 20196 years ago
- Submission Deadline
- 15 Apr 2019Expired
- Future Notice Date
- Not specified
- Award Date
- 8 May 20196 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Contact Name
- Alex Little, Iain Main- NDC Category Manager
- Contact Email
- alex.little1@nhs.net, nss.pcfndccategory@nhs.net
- Contact Phone
- +44 1698794410, +44 1698794586
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR348518
Hepatitis C Medicines - This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing will be requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN356232
Hepatitis C Medicines - This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing was requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000574398-2019-06-04T00:00:00Z",
"date": "2019-06-04T00:00:00Z",
"ocid": "ocds-r6ebe6-0000574398",
"initiationType": "tender",
"parties": [
{
"id": "org-19",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Iain Main- NDC Category Manager",
"email": "nss.pcfndccategory@nhs.net",
"telephone": "+44 1698794586",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
},
{
"id": "Regional or local authority",
"scheme": "TED_CA_TYPE"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-1",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Alex Little",
"email": "Alex.little1@nhs.net",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-227",
"name": "AbbVie Ltd",
"identifier": {
"legalName": "AbbVie Ltd"
},
"address": {
"streetAddress": "Abbvie House, Vanwall Business Park",
"locality": "Maidenhead",
"region": "UK",
"postalCode": "SL6 4UB"
},
"contactPoint": {
"telephone": "+44 7775116875"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-228",
"name": "Gilead Sciences Ltd",
"identifier": {
"legalName": "Gilead Sciences Ltd"
},
"address": {
"streetAddress": "280 High Holborn",
"locality": "London",
"region": "UK",
"postalCode": "WC1V 7EE"
},
"contactPoint": {
"telephone": "+44 7747473021"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-229",
"name": "MSD",
"identifier": {
"legalName": "MSD"
},
"address": {
"streetAddress": "Hertford Road, Hoddesdon",
"locality": "Herts",
"region": "UK",
"postalCode": "EN11 9BU"
},
"contactPoint": {
"telephone": "+44 1992455245"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"id": "org-1"
},
"tender": {
"id": "NP49119",
"title": "Hepatitis C Medicines",
"description": "This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing was requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap",
"status": "complete",
"items": [
{
"id": "2",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "2"
},
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
}
],
"value": {
"amount": 45000000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk",
"tenderPeriod": {
"endDate": "2019-04-15T10:00:00Z"
},
"awardPeriod": {
"startDate": "2019-04-15T10:00:00Z"
},
"documents": [
{
"id": "MAR348518",
"documentType": "contractNotice",
"title": "Hepatitis C Medicines",
"description": "This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing will be requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR348518",
"format": "text/html"
},
{
"id": "JUN356232",
"documentType": "awardNotice",
"title": "Hepatitis C Medicines",
"description": "This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing was requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN356232",
"format": "text/html"
}
],
"lots": [
{
"id": "2",
"title": "Treatment Spend Cap",
"description": "This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.",
"status": "complete",
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Treatment Duration",
"description": "2.5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 660
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s)."
}
},
{
"id": "1",
"title": "Treatment Cost per Medicine",
"description": "This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.",
"status": "complete",
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Treatment Duration",
"description": "2.5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"contractPeriod": {
"durationInDays": 660
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s)."
}
}
],
"lotDetails": {
"maximumLotsBidPerSupplier": 2147483647
},
"bidOpening": {
"date": "2019-04-15T10:00:00Z"
},
"communication": {
"atypicalToolUrl": "https://www.publictendersscotland.publiccontractsscotland.gov.uk"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.",
"minimum": "(a) Confirmation of existence of a current and valid UK Marketing Authorisation, or EMA Marketing Authorisation that has been approved by the MHRA, at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control for all tendered Medicines. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes."
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"hasRecurrence": false,
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
}
},
"language": "EN",
"description": "The estimated value range referred to in Sections II.I.5 and all Lots covers the twenty two (22) months initial duration and the maximum twelve (12) month extension period. (SC Ref:585089)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000574398"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000574398"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP49119-1",
"title": "Treatment Cost per Medicine",
"suppliers": [
{
"id": "org-227",
"name": "AbbVie Ltd"
},
{
"id": "org-228",
"name": "Gilead Sciences Ltd"
},
{
"id": "org-229",
"name": "MSD"
}
],
"relatedLots": [
"1"
]
},
{
"id": "NP49119-2",
"title": "Treatment Spend Cap",
"suppliers": [
{
"id": "org-227",
"name": "AbbVie Ltd"
},
{
"id": "org-228",
"name": "Gilead Sciences Ltd"
}
],
"relatedLots": [
"2"
]
}
],
"contracts": [
{
"id": "NP49119-1",
"awardID": "NP49119-1",
"title": "Treatment Cost per Medicine",
"status": "active",
"value": {
"amount": 9775000,
"currency": "GBP"
},
"dateSigned": "2019-05-08T00:00:00Z"
},
{
"id": "NP49119-2",
"awardID": "NP49119-2",
"title": "Treatment Spend Cap",
"status": "active",
"value": {
"amount": 22808333,
"currency": "GBP"
},
"dateSigned": "2019-05-08T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2019/S 053-121476"
}
],
"bids": {
"statistics": [
{
"id": "386",
"measure": "bids",
"value": 3,
"relatedLot": "1"
},
{
"id": "387",
"measure": "bids",
"value": 2,
"relatedLot": "2"
}
]
}
}